William C. Campbell | |
---|---|
![]() Campbell in Stockholm, December 2015 | |
Born | William Cecil Campbell 28 June 1930 Ramelton, County Donegal, Ireland |
Citizenship | Ireland United States |
Alma mater | Trinity College Dublin University of Wisconsin-Madison (PhD) |
Known for | Discovery of avermectin |
Awards | Membership of NAS (2002) Nobel Prize in Physiology or Medicine (2015) FRS (2020) |
Scientific career | |
Fields | Parasitology |
Institutions | Merck & Co. Drew University |
Thesis | Fascioloides magna (trematoda) with special reference to the adult in relation to disease (1957) |
William Cecil Campbell FRS[1] HonFTCD (born 28 June 1930) is an Irish-American microbiologist, known for his work in discovering a novel therapy against infections caused by roundworms, for which he was jointly awarded the 2015 Nobel Prize in Physiology or Medicine.[2] He helped to discover a class of drugs called avermectins, whose derivatives have been shown to have "extraordinary efficacy" in treating River blindness and Lymphatic filariasis, among other parasitic diseases affecting animals and humans.[3] Campbell worked at the Merck Institute for Therapeutic Research 1957–1990, and has become a research fellow emeritus at Drew University.[4][5]
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search